Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
EpCAM CAR-T -01 | IIT | Solid Tumor | Gastric Cancer |
Expression analysis of human EpCAM on HEK293/Human EpCAM Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human EpCAM Stable Cell Line or negative control cell using PE-labeled anti-human EpCAM antibody.
Immobilized Human EpCAM, Llama IgG2b Fc Tag (Cat. No. EPM-H5259) at 1 μg/mL (100 μL/well) can bind Anti-EpCAM Antibody, Human IgG1 with a linear range of 0.2-8 ng/mL (QC tested).
The purity of Biotinylated Rhesus macaque EpCAM / TROP1 Protein, His,Avitag (Cat. No. EPM-R82E3) is more than 90% and the molecular weight of this protein is around 28-40 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Anti-EPCAM CAR-T cell therapy (Sinobioway) | Phase 2 Clinical | Beijing Sinobioway Bioengineering Group Co Ltd | Liver Neoplasms; Stomach Neoplasms | Details | |
A-337 | A-337 | Phase 1 Clinical | Evive Biotech Ltd | Neoplasms | Details |
Tefibazumab | INH-H2002 | Bristol-Myers Squibb Company | Details | ||
IMC-001 (Immunofoco) | Phase 1 Clinical | Suzhou Immunofoco Biotechnology Co Ltd | Stomach Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details | |
M-701 | M-701 | Phase 2 Clinical | Wuhan Yzy Biopharma Co Ltd, Cspc-Nbp Pharmaceutical Co Ltd | Hydrothorax; Neoplasms; Ascites; Pleural Effusion, Malignant; Carcinoma, Non-Small-Cell Lung | Details |
Catumaxomab | LP000 | Phase 3 Clinical | Trion Research, Neovii Biotech Gmbh | Ovarian Neoplasms; Stomach Neoplasms; Carcinoma; Neoplasms; Carcinoma, Ovarian Epithelial; Colonic Neoplasms; Ascites; Urinary Bladder Neoplasms; Breast Neoplasms | Details |
Oportuzumab monatox | 4D5MOCB-ETA; VB4-845; VB-4847; B-4845; VB-845 | Phase 3 Clinical | Viventia Biotech Inc, Sesen Bio Inc | Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms, Squamous Cell; Urinary Bladder Neoplasms; Carcinoma, Squamous Cell; Mouth Neoplasms | Details |
This web search service is supported by Google Inc.